Conversely, in the recent study by Yu and coworkers, most of the high-grade lesions (7 of 10 NEC samples and 9 of 14 NET-G3 samples) had a positive SSTR2 IHC. Here, SSTR2 is linked to neuroendocrine carcinoma.